share_log

現代牙科：正面盈利預告及內幕消息

MODERN DENTAL: POSITIVE PROFIT ALERT AND INSIDE INFORMATION

香港交易所 ·  Mar 11 07:34
Summary by Moomoo AI
現代牙科集團有限公司（「現代牙科」）於2024年3月11日發布正面盈利預告，預期2023年財政年度的收益、EBITDA及純利均創新高。該預測基於牙科行業數碼化趨勢加快，以及本集團的多元化策略和全面的產品組合，使得市場份額增加。2023年財政年度收益預計介乎31億2千5百萬至32億2千5百萬港元，較2022年增加約10.4%至14.0%。EBITDA預計介乎6億7千5百萬至7億5百萬港元，增加約45.8%至52.3%。純利預計介乎3億9千萬至4億1千萬港元，增加約76.5%至85.5%。本集團將於2024年3月末公佈最終綜合業績。董事會提醒股東及投資者於買賣本公司證券時應審慎行事。
現代牙科集團有限公司（「現代牙科」）於2024年3月11日發布正面盈利預告，預期2023年財政年度的收益、EBITDA及純利均創新高。該預測基於牙科行業數碼化趨勢加快，以及本集團的多元化策略和全面的產品組合，使得市場份額增加。2023年財政年度收益預計介乎31億2千5百萬至32億2千5百萬港元，較2022年增加約10.4%至14.0%。EBITDA預計介乎6億7千5百萬至7億5百萬港元，增加約45.8%至52.3%。純利預計介乎3億9千萬至4億1千萬港元，增加約76.5%至85.5%。本集團將於2024年3月末公佈最終綜合業績。董事會提醒股東及投資者於買賣本公司證券時應審慎行事。
Modern Dental Group Limited (“Modern Dentistry”) issued a positive earnings forecast on March 11, 2024, which expects revenue, EBITDA and net profit for the 2023 fiscal year to be new highs. The forecast is based on the accelerating digitization trend in the dental industry, as well as the Group's diversified strategy and comprehensive portfolio of products, leading to increased market share. Revenue for the 2023 fiscal year is expected to range between HK$31 billion and HK$32 billion, an increase of approximately 10.4% to 14.0% compared to 2022. EBITDA is expected to be in the range of HK$6 billion to HK$7.5 million, an increase of approximately 45.8% to 52.3%. Net profit is expected to be between HK$3.9 million and HK$4 billion, up approximately 76.5% to 85.5%. The Group will announce the final consolidated results by the end of March 2024. The Board of Directors reminds shareholders and investors to exercise caution when buying and selling the Company's securities.
Modern Dental Group Limited (“Modern Dentistry”) issued a positive earnings forecast on March 11, 2024, which expects revenue, EBITDA and net profit for the 2023 fiscal year to be new highs. The forecast is based on the accelerating digitization trend in the dental industry, as well as the Group's diversified strategy and comprehensive portfolio of products, leading to increased market share. Revenue for the 2023 fiscal year is expected to range between HK$31 billion and HK$32 billion, an increase of approximately 10.4% to 14.0% compared to 2022. EBITDA is expected to be in the range of HK$6 billion to HK$7.5 million, an increase of approximately 45.8% to 52.3%. Net profit is expected to be between HK$3.9 million and HK$4 billion, up approximately 76.5% to 85.5%. The Group will announce the final consolidated results by the end of March 2024. The Board of Directors reminds shareholders and investors to exercise caution when buying and selling the Company's securities.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more